PDE5 抑制剂对心血管结果的影响
Imad Ghantous1, Mohamad Tlais2, Ali El Khatib1
1Department of Urology, Saint George Hospital University Medical Center, Beirut, Lebanon.
Global cardiology science & practice
|December 5, 2025
概括
固酶-5抑制剂 (PDE5i) 对勃起功能障碍和心脏病的男性具有心血管益处,降低心脏病发作,心力衰竭和死亡的风险. 患者特定的因素对于最佳结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
背景情况:
- 勃起功能障碍 (ED) 和心血管疾病 (CVD) 具有共同的病理生理机制.
- 勃起障碍通常是潜在心血管风险的早期指标.
- 基化酶-5抑制剂 (PDE5i) 是主要的ED治疗方法,具有血管扩张作用,具有潜在的心血管相关性.
研究的目的:
- 系统地审查PDE5抑制剂对患有ED和心血管疾病同时存在的患者心血管结果的影响.
- 评估PDE5i治疗在该患者队列中的心脏保护潜力和相关风险.
主要方法:
- 对13项相关研究进行了系统审查和元分析.
- 分析的重点是心血管事件 (心肌梗塞,心力衰竭) 和整体死亡率.
- 评估潜在机制,包括内皮功能,炎症和运动能力.
主要成果:
- PDE5 抑制剂对心血管有显著的益处,包括心肌梗塞,心力衰竭和全因死亡率的风险降低.
- 机制包括改善内皮功能,减少全身炎症和提高运动耐受性.
- 在特定人群中观察到中性或不良结局,例如心力衰竭与保存的射出分数和中风后患者.
结论:
- 在ED和心血管疾病患者中,PDE5抑制剂可能具有心脏保护作用.
- 治疗决策必须是个性化的,考虑患者特定的因素和并发症.
- 在高风险人群中,定制的治疗策略对于最大限度地提高益处并最大限度地降低风险至关重要.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
534
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
534
Antianginal Drugs: Nitrates and β-Blockers
1.3K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
439
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
439
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888


